Abstract Details
|
Claire M. Akard
PRESENTER |
Ms. Akard has nothing to disclose. |
| Rayomand V. Kapadia | Mr. Kapadia has nothing to disclose. |
| Amanda Studnicki, PhD | Dr. Studnicki has received personal compensation for serving as an employee of The Geneva Foundation. Dr. Studnicki has received research support from National Institute of Health. |
| Elizabeth Metzger | Ms. Metzger has received personal compensation for serving as an employee of The Geneva Foundation. Ms. Metzger has received research support from University of Michigan . |
| Ethan R. Cheraghpour | Mr. Cheraghpour has nothing to disclose. |
| J. Kent Werner, Jr., MD, PhD (Uniformed Services University) | Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics. |